Oculogenex
PrivateLast Round
Grant
May 1, 2022
Total Funding Raised
$1.28M
Company Overview
Oculogenex is a biotechnology company developing a regenerative gene therapy to treat retinal disorders such as dry age-related macular degeneration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Space Technology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oculogenex Comparables
Compare Oculogenex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Perceive Biotherapeutics, Inc. | 84% | |
| Complement Therapeutics GmbH | 82% | |
| Beacon Therapeutics | 81% |
Oculogenex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 1, 2022 | ||||
| Grant | Oct 28, 2021 | ||||
| Grant | May 1, 2021 | ||||
| Grant | Feb 6, 2021 |
Key People
Founding team and executive leadership
Oculogenex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MassChallenge Israel | Grant |
| The Winning Pitch Challenge | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2022
Received $1M grant from the National Science Foundation.
- Nov 2, 2021
Received grant funding from Boeing and MassChallenge.
Oculogenex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Oculogenex's valuation, stock price, and market status.
Is Oculogenex a public or private company?
Oculogenex is a private company.
What is the current stock price of Oculogenex?
Oculogenex is a private company with no public stock price. No recent secondary market data is available.
How much is Oculogenex worth (valuation)?
Valuation information for Oculogenex is not publicly available.
Can I buy Oculogenex stock?
Oculogenex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Oculogenex's last funding round?
Oculogenex's most recent funding round was Grant on May 1, 2022.
Who are the main investors in Oculogenex?
Key investors in Oculogenex include The Winning Pitch Challenge, National Science Foundation.
Will Oculogenex IPO soon?
No public IPO plans have been announced for Oculogenex.
How can I track Oculogenex secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oculogenex's secondary market activity and sign up for updates.